639 Zhizaoju Road
Shanghai, 200011
China
Neoadjuvant immunochemotherapy, PD-1 inhibitor, Oral squamous cell carcinoma, Major pathological response
adenoid cystic carcinoma, recurrent or metastatic, Apatinib